Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trialsGiuseppe G L Biondi-Zoccai
Istituto di Cardiologia UniversitĂ Cattolica del Sacro Cuore Policlinico A Gemelli Largo A Gemelli, 8 00168 Roma
Ital Heart J 4:271-80. 2003
..We thus undertook a systematic overview of the randomized trials comparing stenting vs CABG in coronary artery disease...
Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patientsGiuseppe G L Biondi-Zoccai
Int J Cardiol 114:104-5. 2007
..66 [0.52-0.84], p=0.0008 for target lesion revascularization). Indeed, such combination of direct and indirect comparisons should also be envisaged to soundly and timely appraise the next generation of drug-eluting stents...
Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent eraPierfrancesco Agostoni
S Raffaele Hospital, Vita e Salute University, Milan, Italy
Am Heart J 151:682-9. 2006
....
The drug-eluting stent dilemma: comparing the effectiveness of Cypher versus TaxusGiuseppe G L Biondi-Zoccai
J Cardiovasc Med (Hagerstown) 7:2-4. 2006
Sirolimus-eluting stents for the treatment of bare-metal in-stent restenosis: long-term clinical follow upImad Sheiban
Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Molinette Hospital, Turin, Italy
J Invasive Cardiol 19:174-80. 2007
..Studies focusing on short- and mid-term follow up support the beneficial role of sirolimus-eluting stents (SES) in the treatment of in-stent restenosis (ISR), yet no long-term safety and/or efficacy data are available...
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) scoreGiuseppe Biondi-Zoccai
Department of Medico Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, Latina, Italy
EuroIntervention 8:359-67. 2012
..We aimed to appraise the predictive accuracy of a novel and user-friendly risk score, the ACEF (age, creatinine, ejection fraction), in patients undergoing PCI for coronary bifurcations...
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis TrialGiuseppe Biondi-Zoccai
Department of Medico Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, Latina, Italy
Am Heart J 163:835.e1-7. 2012
..We aimed to assess the impact of glycoprotein IIb/IIIa (GpIIb/IIIa) inhibition with eptifibatide in clinically stable subjects with diffuse coronary lesions...
Prasugrel during primary percutaneous coronary intervention: evidence from clinical dataGiuseppe Biondi-Zoccai
Division of Cardiology, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena, Italy
Curr Vasc Pharmacol 10:454-7. 2012
..Thus, the use of prasugrel, as well as that of clopidogrel or ticagrelor, should best be individualized to maximize clinical benefits and minimize hazards...
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery diseaseGiuseppe G L Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, Corso Bramante 88 90, 10126 Turin, Italy
Eur Heart J 27:2667-74. 2006
..We thus undertook a systematic review to appraise the hazards inherent to aspirin withdrawal or non-compliance in subjects at risk for or with CAD...
Mastering the antegrade femoral artery access in patients with symptomatic lower limb ischemia: learning curve, complications, and technical tips and tricksGiuseppe G L Biondi-Zoccai
Hemodynamics and Cardiovascular Interventions Service, Abano Terme Hospital, Abano Terme, Italy
Catheter Cardiovasc Interv 68:835-42. 2006
..We appraised learning curve, complications, and technical aspects inherent in the adoption of antegrade approach...
Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary interventionGiuseppe G L Biondi-Zoccai
Division of Cardiology, University of Turin, Turin, Italy
Am Heart J 155:1081-9. 2008
..We systematically reviewed randomized clinical trials (RCTs) on the angiographic and clinical impact of cilostazol after PCI...
Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher)G Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
Minerva Cardioangiol 56:55-65. 2008
..Whether long-term results and direct comparison to Cypher will also be favorable remains to be established by future clinical trials...
Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin RegistryGiuseppe G L Biondi-Zoccai
S Giovanni Battista Molinette Hospital, University of Turin, Italy
Clin Res Cardiol 99:235-42. 2010
..We aimed to retrospectively compare the outcome of patients with ULM treated with DES according to their follow-up management strategy...
Safety of drug-coated stentsGiuseppe Gl Biondi-Zoccai
University of Turin, S Giovanni Battista Molinette Hospital, Interventional Cardiology, Division of Cardiology, Corso Bramante 88 90, 10126 Turin, Italy
Expert Opin Drug Saf 7:597-606. 2008
..However, a number of safety concerns have been raised on DES...
Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case studyGiuseppe G L Biondi-Zoccai
Hemodynamics and Cardiovascular Radiology Service, Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Italy
BMJ 332:202-9. 2006
..To appraise multiple systematic reviews on the same clinical topic, focusing on predictors and correlates of quality of reporting of meta-analysis (QUOROM) scores...
Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patientsGiuseppe G L Biondi-Zoccai
Division of Cardiology, University of Turin, Italy
J Endovasc Ther 16:251-60. 2009
..To report a systematic review of the literature published on the outcomes of stenting for below-the-knee disease in patients with critical limb ischemia (CLI)...
Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regressionGiuseppe G L Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
Am Heart J 153:587-93. 2007
..We performed a systematic review and meta-regression of randomized clinical trials comparing clopidogrel versus ticlopidine, focusing on clopidogrel front-loading...
Percutaneous coronary intervention for small vessel coronary artery diseaseGiuseppe Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, 10126 Turin, Italy
Cardiovasc Revasc Med 11:189-98. 2010
..The present article provides a concise and updated review on percutaneous coronary revascularization in patients with symptomatic small vessel coronary artery disease...
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromesGiuseppe Biondi-Zoccai
Division of Cardiology, University of Turin, San Giovanni Battista Molinette Hospital, Turin, Italy
Int J Cardiol 150:325-31. 2011
..However, there is no comparison of prasugrel vs. ticagrelor. We performed an adjusted indirect meta-analysis comparing prasugrel vs. ticagrelor for acute coronary syndromes (ACSs)...
Intra-arterial lidocaine versus saline to reduce peri-procedural discomfort in patients undergoing percutaneous trans-radial or trans-ulnar coronary proceduresGiuseppe G L Biondi-Zoccai
Division of Cardiology, University of Turin, San Giovanni Battista Molinette Hospital, Turin, Italy
Acta Cardiol 66:9-14. 2011
..We aimed to compare intraarterial lidocaine versus saline to reduce peri-procedural discomfort during percutaneous trans-radial or trans-ulnar procedures...
Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registryGiuseppe Biondi-Zoccai
Division of Cardiology, University of Modena and Reggio Emilia, Modena, Italy
Clin Res Cardiol 100:1021-8. 2011
..We aimed to compare IVUS-guided PCI versus standard PCI in a large registry of patients undergoing PCI for bifurcations in the drug-eluting stent era...
Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplastyGiuseppe Biondi-Zoccai
Division of Cardiology, University of Turin, Turin, Italy
Am Heart J 160:S28-35. 2010
....
Are propensity scores really superior to standard multivariable analysis?Giuseppe Biondi-Zoccai
Division of Cardiology, University of Modena and Reggio Emilia, Modena, Italy
Contemp Clin Trials 32:731-40. 2011
..This qualitative review aims to provide a concise and practical guide to choose between propensity scores and standard multivariable analysis, emphasizing strengths and weaknesses of both approaches...
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patientsGiuseppe Biondi-Zoccai
Divisione di Cardiologia, Universita di Torino, San Giovanni Battista Molinette Hospital, Corso Bramante 88 90, 10126, Turin, Italy
Clin Res Cardiol 100:403-11. 2011
..We thus appraised the prognostic role of left ventricular ejection fraction (LVEF) in patients undergoing PCI for ULM with drug-eluting stents (DES)...
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery diseaseGiuseppe G L Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
Am Heart J 155:274-83. 2008
..Drug-eluting stent (DES) implantation has been recently reported in patients with ULM but with unclear results. We systematically reviewed outcomes of percutaneous DES implantation in ULM...
Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stentsImad Sheiban
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
Am J Cardiol 100:431-5. 2007
..No case of stent thrombosis was reported. In conclusion, this single-center experience suggests that percutaneous use of SESs to treat LM disease in unselected high-risk patients is safe and effective even 1 year after implantation...
The retrograde coronary approach for chronic total occlusions: mid-term results and technical tips & tricksImad Sheiban
Division of Cardiology, University of Turin, Turin, Italy
J Interv Cardiol 20:466-73. 2007
..The retrograde approach is a novel but still incompletely described technique. We report our 5-year-long experience in retrograde percutaneous coronary intervention (PCI) for CTOs...
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis TrialGiuseppe G L Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
J Cardiovasc Med (Hagerstown) 9:957-62. 2008
....
Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation diseaseImad Sheiban
Division of Cardiology, University of Turin, Turin, Italy
Catheter Cardiovasc Interv 73:25-31. 2009
..We aimed to conduct a retrospective cohort study focusing on our 5-year experience in the percutaneous treatment of unprotected left main (ULM) trifurcation disease...
Plantar to dorsalis pedis artery subintimal angioplasty in a patient with critical foot ischemia: a novel technique in the armamentarium of the peripheral interventionistMassimiliano Fusaro
Hemodynamics and Cardiovascular Interventions Service, Abano Terme Hospital, Abano Terme, Italy
J Cardiovasc Med (Hagerstown) 8:977-80. 2007
Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years?Mario Bollati
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
J Cardiovasc Med (Hagerstown) 9:403-5. 2008
..This clinical vignette suggests that suboptimal drug-eluting stent deployment may be associated with stent thrombosis well after the traditional time frame of subacute thrombosis...
Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registryImad Sheiban
Laboratory of Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
J Cardiovasc Med (Hagerstown) 10:461-8. 2009
..Although multivessel disease and stenting are frequent in this population, pertinent details on short-term and long-term outcomes are lacking...
Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stentsGiuseppe G L Biondi-Zoccai
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
EuroIntervention 3:381-5. 2007
....
Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing?Gianfranco Butera
Department of Pediatric Cardiology and GUCH Unit, Policlinico San Donato, IRCCS, San Donato Milanese, Italy
Catheter Cardiovasc Interv 75:494-504. 2010
..To investigate the role of transcatheter closure of patent foramen ovale on the occurrence of migraine...
Meta-analysis of the studies assessing temporal changes in coronary plaque volume using intravascular ultrasoundGaston A Rodriguez-Granillo
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Am J Cardiol 99:5-10. 2007
..13 mm(3), 95% confidence interval -4.42 to 4.68, p = 0.96). In conclusion, statin therapy, particularly when achieving the target LDL level, appears to promote a significant regression of coronary plaque volume as measured by IVUS...
Long-term effect of chronic oral anticoagulation: focus on coronary artery diseaseMarzia Lotrionte
Institute of Cardiology, Catholic University, Rome, Italy
Future Cardiol 5:259-71. 2009
..This review provides a succinct and updated appraisal of the long-term effects of chronic oral anticoagulation in the setting of coronary artery disease...
Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?Pierfrancesco Agostoni
Antwerp Cardiovascular Institute Middleheim, AZ Middelheim, Antwerp, Belgium
Am J Cardiol 97:603-5. 2006
....
Comparison of assessment of native coronary arteries by standard versus three-dimensional coronary angiographyPierfrancesco Agostoni
Antwerp Cardiovascular Institute Middelheim, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
Am J Cardiol 102:272-9. 2008
..In conclusion, 3-dimensional coronary modeling is highly feasible and yields more accurate assessments of the lengths of coronary segments than standard QCA...
Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stentsGiulio Guagliumi
Division of Cardiology, Cardiovascular Department, Ospedali Riuniti di Bergamo, Bergamo, Italy
JACC Cardiovasc Interv 3:531-9. 2010
..We designed a randomized trial exploiting optical coherence tomography (OCT) to assess coverage and apposition of overlapping bare-metal stents (BMS) and drug-eluting stents (DES) in human coronary arteries...
Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesionsImad Sheiban
Interventional Cardiology, Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Turin, Italy
Catheter Cardiovasc Interv 74:313-20. 2009
..We compared our long-term results of a simple vs complex stenting strategy in patients with bifurcation lesions...
Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysisLuca Testa
Department of Interventional Cardiology, Istituto Clinico S Ambrogio, Milan, Italy
EuroIntervention 6:527-36. 2010
..Our aim was to assess, by means of a meta-analytic approach, the risk/benefit profile of drug eluting stents (DES) versus bare metal stents (BMS) in the treatment of SVG disease...
Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) StudyGiulio Guagliumi
Division of Cardiology, Cardiovascular Department, Ospedali Riuniti, Bergamo, Italy
JACC Cardiovasc Interv 3:680-7. 2010
....
Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarctionFabrizio D'Ascenzo
Division of Cardiology, University of Turin, Turin, Italy
Am J Cardiol 107:651-4. 2011
..Also, despite their greater baseline risk profile, women were significantly less likely to have received effective treatment, the use of including drug-eluting stents...
Iatrogenic vessel perforation during below-the-knee percutaneous revascularisation for critical limb ischaemia: successful management with deep catheter intubation and prolonged balloon inflationsMassimiliano Fusaro
Division of Catheterisation and Cardiovascular Radiology, E. Malan Cardiovascular Centre, Policlinico San Donato, San Donato Milanese (MI, Italy
J Cardiovasc Med (Hagerstown) 8:305-8. 2007
Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon?Imad Sheiban
Division of Cardiology, University of Turin, Turin, Italy
J Cardiovasc Med (Hagerstown) 9:783-8. 2008
..We aimed to appraise whether the effectiveness of drug-eluting stents for in-stent restenosis is maintained even in the long term...
Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trialsGiuseppe De Luca
Division of Cardiology, Maggiore della Carita Hospital, Eastern Piedmont University, C so Mazzini, 18, 24100 Novara, Italy
Int J Cardiol 126:37-44. 2008
....
The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary interventionEugenio Stabile
Laboratory of Invasive Cardiology, Division of Cardiology, Clinica Montevergine, Mercogliano, Italy
J Am Coll Cardiol 52:1293-8. 2008
..We sought to evaluate, in a double-blind, randomized, prospective study, safety and efficacy of elective percutaneous coronary intervention (PCI), with pharmacotherapy consisting of antiplatelet therapy and no anticoagulation therapy...
Percutaneous coronary intervention on left main coronary artery trifurcationMatteo Anselmino
Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Turin, Italy
Heart Vessels 23:279-81. 2008
..We therefore describe a case of successful PCI on a left main trifurcation supported by pre-and post-intravascular ultrasound iconography...
Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteriesImad Sheiban
Interventional Cardiology, Division of Cardiology, University of Turin, San Giovanni Battista Hospital, Turin, Italy
Clin Res Cardiol 97:891-8. 2008
..The aim of the present study was to test in a porcine model the safety and efficacy of a novel Genistein-eluting balloon preceding coronary stenting...
A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesionsFrancesco Colombo
Division of Cardiology, University of Turin, S Giovanni Battista Molinette Hospital, Turin, Italy
Acta Cardiol 64:583-8. 2009
..We thus aimed to appraise the long-term (> 2 years) outcomes of patients with bifurcation lesions treated with DES vs. BMS...
Sex-related differences in patients undergoing percutaneous unprotected left main stentingImad Sheiban
Divisione di Cardiologia, Universita di Torino, Turin, Italy
EuroIntervention 5:795-800. 2010
..Limited data are available on sex-related differences in this setting. We investigated gender-associated differences in patients undergoing stent-based PCI for ULM...
Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary diseaseImad Sheiban
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
J Cardiovasc Med (Hagerstown) 9:1246-53. 2008
..Percutaneous coronary intervention with drug-eluting stent implantation is increasingly used for ULM disease. However, there are no data on the clinical results of drug-eluting stents for ULM disease in patients with diabetes...
Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic functionMario Bollati
Division of Cardiology, University of Turin, Turin, Italy
Catheter Cardiovasc Interv 75:586-93. 2010
..We aimed to appraise the early and long-term outcome after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in patients with unprotected left main disease (ULM) and left ventricular systolic dysfunction (LVD)...
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Imad Sheiban
Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
Vasc Health Risk Manag 4:31-8. 2008
..Only indirect meta-analyses can be used to date to compare the Xience V with the Cypher. This systematic review tries to provide a concise and critical appraisal of the data in support of the Xience V everolimus-eluting stent...
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study)Imad Sheiban
University of Turin, Italy
J Am Coll Cardiol 54:1131-6. 2009
..This study sought to retrospectively appraise the incidence and management of restenosis after drug-eluting stent (DES) implantation for unprotected left main (ULM) disease...
Update on dedicated bifurcation stentsImad Sheiban
From the Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
J Interv Cardiol 22:150-5. 2009
..The development of further drug-eluting platforms and larger controlled studies should demonstrate their clinical applicability, efficacy, and safety before they are widely incorporated into daily practice...
Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trialsGiuseppe De Luca
Division of Cardiology, Maggiore della Carita Hospital, Eastern Piedmont University A Avogadro, Novara, Italy
Ann Emerg Med 52:665-76. 2008
....
Impact of multivessel coronary disease on long-term outcome after percutaneous recanalization of coronary chronic total occlusionsC La Spina
Division of Cardiology, University of Turin, Turin, Italy
Minerva Cardioangiol 58:159-65. 2010
..Percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) is common even with concomitant multivessel disease. We aimed to investigate the impact of multivessel disease on long-term outcome after PCI for CTO...
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCIMaria De Vita
Institute of Cardiology, Catholic University, Via B Barbiellini Amidei, 80, 00168, Rome, Italy
J Invasive Cardiol 20:161-5. 2008
..Due to the high thrombus burden present in ST, the use of thrombus aspiration (TA) may enhance the angiographic results by limiting distal embolization...
Rationale for intracoronary administration of abciximabEnrico Romagnoli
Department of Cardiovascular Disease, Catholic University, Campobasso, Italy
J Thromb Thrombolysis 23:57-63. 2007
..On such basis, the present review aims to describe the pharmacological aspects as well as the available clinical data supporting the choice of intracoronary route of administration for abciximab...
Comparison of different methods of measurement of aspirin resistance: using the appropriate statisticMarzia Lotrionte
Eur Heart J 29:138; author reply 138-9. 2008
Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trialsPierfrancesco Agostoni
Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Piazzale Stefani 1, 37126 Verona, Italy
Eur Heart J 26:881-9. 2005
..To compare, by meta-analytical techniques, the clinical impact of bare-metal stenting vs. balloon angioplasty for the treatment of lesions in small coronary arteries...
Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) StudyGiuseppe G L Biondi-Zoccai
Int J Cardiol 108:406-7. 2006
..These findings thus support the overall safety and effectiveness of ticlopidine after DES implantation, and also confirm the increased risk of late thrombosis when premature withdrawal of thienopyridines occurs...
Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trialsGiuseppe G L Biondi-Zoccai
Invasive Cardiology, San Raffaele Hospital, and EMO Centro Cuore Columbus, Milan, Italy
Int J Cardiol 100:119-23. 2005
..Drug-eluting stents (DES) have been recently investigated, with favorable data for many devices, but comparative data are lacking. We thus performed an adjusted indirect comparison metaanalysis of DES...
Drawbacks of nonrandomized trials in acute coronary syndromesGiuseppe G L Biondi-Zoccai
Am J Cardiol 97:151. 2006
Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesionsJohn Cosgrave
EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
Am J Cardiol 96:1663-8. 2005
..Overall, the 2 available stent platforms had similar performance characteristics...
Percutaneous saphenectomy: a potentially dreadful complication of cutting balloon angioplasty in saphenous vein graftsWorawut Tassanawiwat
Int J Cardiol 106:418-9. 2006
..This clinical vignette emphasizes the role of optimal backup in order to deploy life-saving devices and successfully manage life-threatening pericardial tamponade due to SVG rupture...
Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregressionGiuseppe G L Biondi-Zoccai
Institute of Cardiology, Catholic University, Rome, Italy
Am Heart J 149:504-11. 2005
..We performed a metaregression to explore the impact of intracoronary stenting and aggressive antiplatelet treatment on the risk/benefit ratio of an early invasive approach...
Ischemic cardiomyopathy, left coronary trunk hypoplasia and subsidiary coronary supply from the descending thoracic aortaTommaso Langialonga
Divisione di Cardiologia, Ospedale Casa Sollievo della Sofferenza, S. Giovanni Rotondo, Italia
Int J Cardiol 106:139-40. 2006
....
Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantationGiuseppe G L Biondi-Zoccai
Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy
Eur Heart J 27:540-6. 2006
....
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patientsFelicita Andreotti
Institute of Cardiology, Catholic University, Largo F Vito, 00168, Rome, Italy
Eur Heart J 27:519-26. 2006
..We conducted a specific meta-analysis of randomized trials comparing aspirin plus warfarin (A+W) with aspirin alone in such patients...
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery diseaseFlavio Airoldi
Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy
Am J Cardiol 96:664-7. 2005
..47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-beta-E eluting stent over the control PC stent...
Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent eraGiuseppe G L Biondi-Zoccai
St. Raffaele Hospital, Milan, Italy
Am J Cardiol 95:1466-8. 2005
..Such results may provide useful information to guide prevention of this complication...
Drug-eluting stent restenosis the pattern predicts the outcomeJohn Cosgrave
EMO Centro Cuore Columbus, Milan, Italy
J Am Coll Cardiol 47:2399-404. 2006
..CONCLUSIONS: Similar to bare-metal stent data, the angiographic pattern of restenosis following DES implantation is prognostically important. Diabetes is a significant predictor of the pattern of restenosis in the DES era...
Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Giuseppe G L Biondi Zoccai
Mediolanum Cardio Research, Milan, Italy
Int J Cardiol 117:349-54. 2007
..Indeed, the TRUE Study, including as much as 115 ULM and 229 bifurcation interventions, should give important insights into the outcome of PES in such an unprecedented and challenging context...
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary interventionMarzia Lotrionte
Institute of Cardiology, Catholic University, Rome, Italy
Am J Cardiol 100:1199-206. 2007
..In conclusion, a high clopidogrel loading dose (>300 mg) significantly reduces early ischemic events in patients scheduled for percutaneous coronary intervention...
Late restenosis following sirolimus-eluting stent implantationJohn Cosgrave
EMO Centro Cuore Columbus, Milan, Italy
Am J Cardiol 100:41-4. 2007
..In conclusion, late restenosis is an infrequent but real entity; its existence implies we should not discount the possibility of restenosis as the cause of symptoms that develop >1 year after sirolimus-eluting stent implantation...
Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practiceJohn Cosgrave
EMO Centro Cuore Columbus, Milan, Italy
J Am Coll Cardiol 49:2320-8. 2007
..This study was designed to compare the outcomes of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) in a contemporaneous cohort of real-world patients...
Recurrent angina after coronary revascularization: a clinical challengeAntonio Abbate
Division of Cardiology, West Hospital, Virginia Commonwealth University VCU Pauley Heart Center, 1200 E, Marshall Street, PO Box 980036, Richmond, VA 23298 0036, USA
Eur Heart J 28:1057-65. 2007
..This review attempts to summarize the most common causes of recurrent chest pain after coronary revascularization, to analyse the possible diagnostic approaches, and to discuss the potential treatment modalities...
Adjunctive devices in primary or rescue PCI: a meta-analysis of randomized trialsFrancesco Burzotta
Institute of Cardiology, Catholic University of the Sacred Heart, Via Prati Fiscali 158, 00141 Rome, Italy
Int J Cardiol 123:313-21. 2008
....
Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stentsPierfrancesco Agostoni
San Raffaele Hospital, Milan, Italy
Am J Cardiol 99:593-8. 2007
..Thus, late loss may not be a reliable marker of the true efficacy of these devices due to its complex and nongaussian distribution...
Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stentJohn Cosgrave
EMO Centro Cuore Columbus, Milan, Italy
Am Heart J 153:354-9. 2007
..Currently, little data are available on the management of drug-eluting stent (DES) restenosis. Drug resistance may play a role in its etiology...
Keeping a high standard in quantitative analyses, meta-analyses, and systematic reviewsGiuseppe G L Biondi-Zoccai
Eur Heart J 28:516-7; author reply 517-8. 2007
Preprocedural C-reactive protein for risk prediction before percutaneous coronary intervention (PCI): a European perspectiveLuigi M Biasucci
Clin Chem 50:1492-4. 2004
Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: a case seriesGiuseppe G L Biondi-Zoccai
Int J Cardiol 118:398-9. 2007
....
Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stentsSimon J Corbett
EMO Centro Cuore Columbus, 48 Via M. Buonarroti, 20145 Milan, Italy
Eur Heart J 27:2330-7. 2006
..In contrast, just under half of restenosis in PES is the more severe non-focal pattern. Paradoxically, the majority of focal restenosis occurs at the proximal stent margin for both platforms...
Antegrade access in a stented common femoral artery: feasible but with a real bleeding riskGiuseppe G L Biondi-Zoccai
Int J Cardiol 114:E68-9. 2007
..This clinical vignette, the first to date to report on antegrade access in a stented femoral artery, supports its feasibility despite the presence of a real bleeding risk...
Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trialsPierfrancesco Agostoni
Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Verona, Italy
J Am Coll Cardiol 44:349-56. 2004
..We sought to compare, through a meta-analytic process, the transradial and transfemoral approaches for coronary procedures in terms of clinical and procedural outcomes...
Critical role of bare-metal stent controls in trials of drug-eluting stentsGiuseppe G L Biondi-Zoccai
Eur Heart J 26:1686-7; author reply 1687. 2005
Rescue percutaneous coronary intervention for failed thrombolysis in a patient with anomalous coronary arteriesMario Mazzari
Int J Cardiol 99:325-6. 2005
....
Use of a novel high-osmolar gadolinium chelate, gadobutrol, for percutaneous renal artery stenting in two patients with chronic renal failureCarlo Trani
Int J Cardiol 102:361-2. 2005
..In both patients gadobutrol yielded high-quality images without digital subtraction and was well tolerated with no ensuing renal dysfunction...
Coronary stenting versus balloon angioplasty in small vesselsPierfrancesco Agostoni
J Am Coll Cardiol 45:323-4; author reply 324-5. 2005
Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardiumAntonio Abbate
Department of Medicine, Virginia Commonwealth University MCV Campus, Richmond, VA, USA
Eur Heart J 26:2039-45. 2005
..It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium...
Clinical implications of the PROTECT-TIMI-30 trialMarco Valgimigli
J Am Coll Cardiol 49:729-30; author reply 730-1. 2007
Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysisMichele Hamon
Department of Radiology of the University Hospital of Caen, Caen, Normandy, France
J Am Coll Cardiol 48:1896-910. 2006
..This study was designed to define the current role of multislice spiral computed tomography (MSCT) for the diagnosis of coronary artery disease (CAD) using a meta-analytic process...
A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with thrombus-containing lesions: the Diver C.E. studyFrancesco Burzotta
Institute of Cardiology, Catholic University, Rome, Italy
Catheter Cardiovasc Interv 67:887-93. 2006
..Thus, interventional techniques able to reduce thrombus burden at the culprit vessel might improve final myocardial reperfusion...
Low-dose aspirin for stroke preventionLuca Testa
Stroke 37:1356. 2006
Potentials and pitfalls of clinical outcome research studies in cardiac surgeryGiuseppe G L Biondi-Zoccai
Eur J Cardiothorac Surg 29:855-6; author reply 856. 2006
Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarctionAntonio Abbate
Institute of Cardiology, Catholic Univeristy, Rome, Italy
Circulation 106:1051-4. 2002
..These data may suggest that the post-AMI benefits observed with a patent IRA (the "open-artery hypothesis") may in part be due to reduced myocardial apoptosis...
New insights into molecular mechanisms of diffuse coronary ectasiae: a possible role for VEGFMarinica Savino
Institute of Cardiology, Catholic University of the Sacred Heart, Largo A. Gemelli 8, 00168 Rome, Italy
Int J Cardiol 106:307-12. 2006
....
Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trialFrancesco Burzotta
Institute of Cardiology, Catholic University, Rome, Italy
J Am Coll Cardiol 46:371-6. 2005
..The aim of this study was to evaluate the use of a new manual thrombus-aspirating device in unselected patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing urgent percutaneous coronary intervention (PCI)...